NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Change of Director's Interest Notice, page-37

  1. 3,043 Posts.
    lightbulb Created with Sketch. 249
    Wasa- have a read of the interim trial result for Retts, evidence of efficacy? Enough alteady to snag a licence deal imo but those BD & OD applications will add to the value immensely. I think FDA will only grant orphan drug status on proof that it was a positive effect on its target, so OD will be huge going forward. Big Pharma like orphan drugs and ours have NO competition.

    Price - I don't care, I just want OD for Trof, and guidance from the FDA on the next steps... Then let's have a great outcome for the FX trial. We should all be hoping the price doesn't move from current levels so we can accumulate more...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.